ArticleNucleic acids research2026
Discovery and biosynthesis of a novel diaminopropane-modified thymine in phage DNA.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bacteriophage genomes exhibit exceptional diversity in nucleotide modifications, which primarily function to counteract host defense systems. However, the diversity of phage DNA hypermodifications remains largely unexplored in post genome era. Here, we discovered a novel thymine hypermodification, α-1,3-diaminopropanylthymine (α-dapT), in the Acinetobacter baumannii phage SH-Ab 15599, and elucidated its biosynthetic pathway, featuring the phage-encoded key diamine DNA transferase (DADT, formerly αGPT-Pplase2). DADT utilizes the metabolite 1,3-diaminopropane, which is the major polyamine in the host to modify phage DNA. DADT exhibits broad in vitro substrate specificity but a strong in vivo preference for 1,3-diaminopropane. Structural and mutagenesis analyses revealed the molecular basis for substrate recognition and catalysis. The α-dapT modification occurs preferentially at TG dinucleotides and confers resistance to multiple host restriction enzymes. Furthermore, RNA-seq analysis showed that phage infection upregulates genes for 1,3-diaminopropane synthesis, and downregulates genes for 1,3-diaminoproprane consumption to supply the modification precursor. Given that 1,3-diaminopropane functions as a key regulator in mobility of A. baumannii, its metabolic reprograming may impair host biofilm formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.